Challenge Qualité de vie du patient 2018 : l’appel à projets est ouvert !
GenePOC launches its revogene™ instrument and GBS LB test in Canada
Debiopharm continues the fight against antibiotic resistance with investment in ABAC Therapeutics Inc.
Debiopharm's vision of healthcare is not limited to making new medicines available. We strongly believe that you can be an actor in your own medical care. Your safety is our top priority.MORE ABOUT CLINICAL TRIALS
April 14, 2018
WATCH ALL EVENTS
© 2018 Debiopharm Group™